Key Insights

Highlights

Success Rate

63% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 67/100

Termination Rate

25.0%

3 terminated out of 12 trials

Success Rate

62.5%

-24.0% vs benchmark

Late-Stage Pipeline

33%

4 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

63% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (2)
P 1 (1)
P 3 (4)

Trial Status

Completed5
Terminated3
Recruiting2
Withdrawn1
Active Not Recruiting1

Trial Success Rate

62.5%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (12)

Research Network

Activity Timeline